Liquidity & Technicals
Liquidity & Technicals
The verdict in two sentences. Wise trades £16.0M of stock per day against a £13.3B market cap — a turnover ratio of 0.12% that puts the name in capacity-constrained specialist territory; a 0.5% issuer-level position needs three weeks to build or exit at 20% participation. Technically, price has clawed back above the 200-day SMA after a November death-cross sell-off, but the 50-day still trades below the 200-day and the rally has run on shrinking volume — constructive but unconfirmed.
Portfolio implementation verdict
5-day capacity @ 20% ADV (£M)
Max 5-day position (% mcap)
Fund AUM @ 5% weight (£M)
ADV / mcap (%)
Tech stance score
Capacity-constrained, specialist sizing only. Daily turnover is 0.12% of market cap; even patient execution at 20% of ADV builds only £16M in five sessions. Position weights of 5% are realistic for funds up to roughly £320M; a 1% issuer-level stake takes six weeks to exit. Liquidity, not the chart, is the binding constraint.
Price snapshot
Last price (£)
YTD return (%)
1-year return (%)
52-week position (percentile)
1-month return (%)
Beta is omitted: no UK broad-market benchmark series was loaded for this run, and a single-asset history without a paired index cannot anchor a defensible beta.
Trend — full price history with 50/200-day SMA
Most recent moving-average cross: death cross on 10 November 2025 (50-day fell below 200-day). Price has since rallied roughly 30% off the £8.04 trough, but the 50-day SMA (£9.42) remains below the 200-day SMA (£9.61) — the bearish configuration has not yet flipped.
Price is above the 200-day SMA by 8.7%. The post-IPO history splits into three clean regimes: a year-long de-rating from the £8.80 direct-listing reference to the £2.94 all-time low in October 2022; a recovery through 2023–2024 that printed two golden crosses (July 2023, December 2024); and a renewed downtrend through mid-2025 that produced the November 2025 death cross. The current setup is a textbook recovery-from-death-cross — price has reclaimed the 200-day but the moving-average configuration has not confirmed.
Relative strength vs benchmark + sector
No benchmark series was successfully loaded for this run (UK broad-market ETF EWU was the intended reference). Sector ETF and peer basket are also unavailable. Relative-strength analysis is deferred — the company-only series is shown above; pair-against-index comparisons should be sourced from the Quant or Variant pages.
Momentum — RSI(14) and MACD histogram, last 18 months
RSI sits at 60.8 — bullish but not overbought; the indicator has held above 50 for most of the last six weeks, consistent with the rally. MACD is the more cautious read: the line is positive at +33.1 but already crossed below its signal line, and the histogram has flipped negative (−6.7) — momentum is decelerating even as price grinds higher. The combination is a near-term bullish-but-fading setup, the kind that often gives back recent gains before resolving in either direction.
Volume, volatility, and sponsorship
The most striking feature: the recent 16% one-month rally has run on below-average volume. The 5-day average sits near 1.0M shares against a 50-day average of 1.74M — sponsorship is not confirming the move. Combined with the MACD divergence, this is the single weakest element of the technical picture.
Top volume events (5-year window)
The 31 May 2023 print — 22.6× average volume on an 8.3% rally — coincides with Wise's FY23 full-year results and stands out as the cleanest positive earnings reaction in the post-IPO record. The other top spikes are mostly downside reactions to mid-period updates.
Realized volatility (30-day rolling, 5-year history)
Realized vol is currently 29.5% — between the 5-year p20 (25.2%) and p50 (34.7%) bands, which the methodology classifies as normal-to-calm. That matters: the recent rally is not the kind of vol-crush mean reversion that follows a panic. It is being absorbed in an orderly tape, which makes patient accumulation defensible — but also means there is no compressed-vol catalyst force-feeding upside.
Institutional liquidity panel
This name is flagged illiquid in the run manifest. Average daily turnover of £16M against a £13.3B market cap means even moderate institutional positions face multi-week execution windows. The numbers below are computed from clean, observed trading (100% volume coverage, zero zero-volume days over 60 sessions) — the constraint is real, not a data artefact.
ADV and turnover
ADV 20d (M shares)
ADV 20d (£M)
ADV 60d (M shares)
ADV / mcap (%)
Annual turnover (% float)
Fund-capacity table
Reverse the math: at a normal 20% participation rate, a fund running this name as a 5% position needs to be £323M or smaller to clear the 5-day execution test; a 2% position works up to £807M. At a more conservative 10% participation, those numbers halve. For most multi-billion equity funds, Wise is either a bench-position or an out-of-bench specialist sleeve — not a flagship holding.
Liquidation runway
A 0.5%-of-mcap position (£66M) takes three trading weeks to exit at full institutional aggression and over two months at a more cautious 10% rate. A 1% position is a six-to-seventeen-week project. No issuer-level position size of 0.5% or larger clears the 5-day threshold — the data field reads 0.0%.
Execution friction
The 60-day median daily range is 1.10% — under the 2% threshold above which intraday impact starts compounding. Bid-ask cost is not the problem here; the problem is sheer volume per day relative to mcap. There are no zero-volume days in the trailing 60-session window, and volume coverage is 100%. The friction is one of capacity, not of trading microstructure.
Technical scorecard and stance
Net score: +1. Stance: neutral with a bullish lean over the 3-to-6 month horizon. The recovery from the November 2025 death cross is real — price has reclaimed the 200-day SMA on a normal-vol tape — but the rally lacks the volume signature that usually accompanies a durable trend change, and the MACD has begun to fade. A break above £11.60 (the 52-week high) closes out the bearish moving-average configuration and validates the recovery; a loss of £9.60 (the 200-day SMA) marks the rally as a counter-trend bounce and reopens the path to the £8.04 52-week low. Liquidity is the constraint, not the tape: even with a constructive technical view, this is a slow-build name suitable for funds under £320M targeting a 5% weight, or larger funds willing to run it as a sub-2% specialist position over multiple weeks.